479 related articles for article (PubMed ID: 19293072)
1. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.
US Preventive Services Task Force
Ann Intern Med; 2009 Mar; 150(6):396-404. PubMed ID: 19293072
[TBL] [Abstract][Full Text] [Related]
2. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T; Miller T; Ko S
Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Bibbins-Domingo K;
Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
; Davidson KW; Barry MJ; Mangione CM; Cabana M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Krist AH; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Tseng CW; Wong JB
JAMA; 2022 Apr; 327(16):1577-1584. PubMed ID: 35471505
[TBL] [Abstract][Full Text] [Related]
5. Aspirin for the prevention of cardiovascular disease: recommendation statement.
Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
[No Abstract] [Full Text] [Related]
6. Compliance with USPSTF recommendations on aspirin for prevention of cardiovascular disease in men.
Malayala SV; Raza A
Int J Clin Pract; 2016 Nov; 70(11):898-906. PubMed ID: 27619938
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
[TBL] [Abstract][Full Text] [Related]
9. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
Mutter J; Grandy R; Hulkower S; Stigleman S
J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for Primary Prevention.
Richman IB; Owens DK
Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for the prevention of cardiovascular disease.
Lin KW
Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
[No Abstract] [Full Text] [Related]
12. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
13. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
14. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
Wynn RL
Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
[No Abstract] [Full Text] [Related]
15. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.
Michaud TL; Abraham J; Jalal H; Luepker RV; Duval S; Hirsch AT
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702086
[TBL] [Abstract][Full Text] [Related]
18. Aspirin use for primary prevention in elderly patients.
Terrosu P
Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
[TBL] [Abstract][Full Text] [Related]
19. Should This Patient Receive Aspirin?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Burns RB; Graham K; Sawhney MS; Reynolds EE
Ann Intern Med; 2017 Dec; 167(11):786-793. PubMed ID: 29204620
[TBL] [Abstract][Full Text] [Related]
20. Aspirin Use for the Primary Prevention of Myocardial Infarction Among Men in North Carolina, 2013.
Tchwenko S; Fleming E; Perry GS
Prev Chronic Dis; 2015 Nov; 12():E202. PubMed ID: 26583574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
